| Literature DB >> 27766275 |
Ingrid Eitzen1, Hege Grindem2, Agnethe Nilstad1, Håvard Moksnes2, May Arna Risberg3.
Abstract
BACKGROUND: Reduced quadriceps strength influences knee function and increases the risk of knee osteoarthritis. Thus, it is of significant clinical relevance to precisely quantify strength deficits in patients with knee injuries.Entities:
Keywords: ACL; articular cartilage; knee; meniscus; physical therapy/rehabilitation
Year: 2016 PMID: 27766275 PMCID: PMC5063093 DOI: 10.1177/2325967116667717
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Overview of Original Studies
| Delaware-Oslo ACL Cohort Study | Oslo CARE Study | OMEX Study | |
|---|---|---|---|
| Time of inclusion | January 2007 to September 2011 | June 2008 to January 2010 | October 2009 to December 2011 |
| Referral | From primary care for consideration of arthroscopic surgery | From primary care for consideration of arthroscopic surgery | From primary care for consideration of arthroscopic surgery |
| Inclusion criteria |
Men and women aged 13-60 y Participation at least 2 times a week in pivoting sports before injury Unilateral acute complete rupture of the ACL within the past 3 mo |
Men and women aged 17-50 y Arthroscopically verified full-thickness cartilage lesion (classified as grade 3 or 4) on either femoral condyle No ligamentous instability Lysholm score <75 |
Men and women aged 35-60 y Unilateral knee pain for more than 2 mo without significant trauma Degenerative tear of the meniscus confirmed by MRI Eligible for arthroscopic surgery |
| Exclusion criteria |
Bilateral injury Previous injury to either knee Concomitant grade 3 knee ligament injury, fracture, or full-thickness articular cartilage injuries shown on MRI Meniscus injuries with symptoms that were not resolved within 3 mo from injury Inability to participate in the rehabilitation program due to geography or workload |
Bilateral injury Untreated meniscal injury Inability to participate in the rehabilitation program due to geography or workload |
Bilateral injury Acute knee locking Ligament injuries Knee surgery within the past 2 y Inability to participate in the rehabilitation program due to geography or workload |
| Time since injury/duration of symptoms at inclusion | Time since injury: 8 wk (range, 3-12 wk) | Duration of symptoms: 46 mo (range, 41-51 mo) | Duration of symptoms: 7 mo (range, 5-12 mo) |
| Participants Eligible at baseline | 150 | 48 | 69 |
| Lost to follow-up at retest | 6 | 4 | 7 |
| Included | 144 | 44 | 62 |
ACL, anterior cruciate ligament; MRI, magnetic resonance imaging.
The total number of patients included in the OMEX study was 150, but the patients randomized to surgery were not included in the present study.
Reasons lost to follow-up: Delaware-Oslo ACL cohort study: unable to reach/did not respond, n = 2; swelling and unable to perform strength test, n = 2; loss of angle-specific data due to technical problems, n = 2. OMEX study: unable to reach/did not respond, n = 3; did not show at test day, n = 2; noncompliant to rehabilitation program n = 2. Oslo CARE study: withdrew from study, n = 3; did not show at test day, n = 1.
Demographics of Patients With an ACL Injury, Degenerative Meniscus Tear, and Focal Cartilage Lesions
| ACL Injury (n = 144) | Focal Cartilage Lesion (n = 44) | Degenerative Meniscus Tear (n = 62) |
| Post Hoc | |
|---|---|---|---|---|---|
| Age, y | 25.9 ± 8.1 | 34.3 ± 9.3 | 50.2 ± 6.2 | <.001 | All <.001 |
| Height, cm | 174.6 ± 9.0 | 177.8 ± 9.2 | 175.8 ± 8.4 | .109 | |
| Weight, kg | 72.7 ± 13.7 | 86.2 ± 15.6 | 81.1 ± 16.3 | <.001 | ACL vs Men: <.001 ACL vs Cart: <.001 |
| BMI, kg/m2 | 23.7 ± 3.1 | 27.3 ± 5.0 | 26.1 ± 4.0 | <.001 | ACL vs Men: <.001 ACL vs Cart: <.001 |
| Weeks from baseline to retest | 5.1 ± 2.1 | 14.3 ± 2.3 | 16.7 ± 2.5 | <.001 | All: <.001 |
| Women, n (%) | 82 (55.0) | 13 (31.0) | 24 (38.7) | .007 | ACL vs Men: .031 ACL vs Cart: .006 |
Data are presented as mean ± SD unless otherwise specified. ACL, anterior cruciate ligament; BMI, body mass index; Cart, patients with focal cartilage lesions; Men, patients with a degenerative meniscus tear.
Peak Torque Quadriceps Strength for Both Legs at Baseline and Retest, Deficit at Peak Torque, and Largest Deficit During Movement
| ACL Injury (n = 144) | Focal Cartilage Lesion (n = 44) | Degenerative Meniscus Tear (n = 62) |
| Post Hoc | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Retest |
| Baseline | Retest |
| Baseline | Retest |
| |||
| Peak torque involved, N·m | 173.0 ± 48.1 | 188.7 ± 48.8 | <.001 | 139.8 ± 65.9 | 176.5 ± 61.1 | <.001 | 157.1 ± 47.0 | 179.8 ± 47.9 | <.001 | .001 | ACL vs Men: .041 ACL vs Cart <.001 |
| Peak torque uninvolved, N·m | 194.5 ± 51.0 | 203.5 ± 51.6 | <.001 | 196.3 ± 55.5 | 204.8 ± 56.1 | .100 | 179.4 ± 47.1 | 189.4 ± 46.7 | .009 | .113 | |
| Peak torque involved, N·m/BW | 2.37 ± 0.42 | 2.59 ± 0.42 | <.001 | 1.63 ± 0.69 | 2.06 ± 0.64 | <.001 | 1.97 ± 0.54 | 2.25 ± 0.59 | <.001 | <.001 | ACL vs Men: <.001 ACL vs Cart: <.001 Men vs Cart: .001 |
| Peak torque uninvolved, N·m/BW | 2.67 ± 0.44 | 2.79 ± 0.45 | <.001 | 2.29 ± 0.55 | 2.39 ± 0.56 | .092 | 2.23 ± 0.50 | 2.36 ± 0.55 | .002 | <.001 | ACL vs Men: <.001 ACL vs Cart: <.001 |
| Deficit at PT, % | 10.8 ± 10.3 | 6.8 ± 9.4 | <.001 | 29.1 ± 22.9 | 14.1 ± 16.1 | <.001 | 12.0 ± 14.5 | 3.8 ± 17.9 | <.001 | <.001 | ACL vs Cart: <.001 |
| Largest deficit, % | 21.7 ± 13.2 | 16.8 ± 13.9 | <.001 | 39.7 ± 24.3 | 24.7 ± 18.5 | <.001 | 20.7 ± 16.3 | 13.3 ± 17.8 | .004 | <.001 | ACL vs Cart: <.001 |
Data presented as mean ± SD. ACL, anterior cruciate ligament; BW, body weight; Cart, patients with focal cartilage lesions; Men, patients with a degenerative meniscus tear; PT, peak torque.
Angle-Specific Quadriceps Strength for Both Legs at Baseline and Retest
| Involved Leg | Uninvolved Leg | |||||
|---|---|---|---|---|---|---|
| Baseline | Retest | Change | Baseline | Retest | Change | |
| ACL injury | ||||||
| 70° | 154.1 ± 41.7 | 169.2 ± 46.6 | 15.1 ± 20.5 | 169.3 ± 50.9 | 184.7 ± 50.8 | 15.5 ± 23.3 |
| 60° | 166.5 ± 46.2 | 184.7 ± 49.0 | 18.2 ± 20.3 | 186.8 ± 50.8 | 197.9 ± 51.7 | 11.1 ± 21.2 |
| 50° | 156.9 ± 44.7 | 174.0 ± 47.4 | 17.1 ± 21.4 | 175.9 ± 46.5 | 182.9 ± 46.5 | 7.0 ± 24.1 |
| 40° | 133.9 ± 41.4 | 148.3 ± 42.7 | 14.4 ± 22.3 | 151.2 ± 40.6 | 155.3 ± 40.8 | 4.1 ± 22.8 |
| 30° | 105.8 ± 35.9 | 118.5 ± 38.2 | 12.7 ± 20.5 | 119.9 ± 33.1 | 125.0 ± 35.3 | 5.1 ± 20.3 |
| 20° | 78.7 ± 29.2 | 86.5 ± 32.8 | 7.8 ± 18.2 | 89.2 ± 27.0 | 91.4 ± 27.8 | 2.2 ± 16.7 |
| Degenerative meniscus tear | ||||||
| 70° | 142.1 ± 46.7 | 164.5 ± 46.8 | 22.4 ± 31.5 | 160.8 ± 45.7 | 174.7 ± 46.4 | 14.0 ± 25.8 |
| 60° | 155.1 ± 46.7 | 175.1 ± 49.1 | 20.1 ± 29.6 | 173.9 ± 46.0 | 186.2 ± 46.4 | 12.3 ± 25.9 |
| 50° | 149.4 ± 42.9 | 166.2 ± 45.4 | 16.8 ± 26.4 | 166.7 ± 41.6 | 174.7 ± 43.0 | 8.0 ± 25.6 |
| 40° | 132.2 ± 37.1 | 140.6 ± 40.1 | 8.3 ± 25.4 | 143.7 ± 34.6 | 146.6 ± 40.0 | 2.9 ± 26.0 |
| 30° | 106.7 ± 31.2 | 113.7 ± 34.4 | 7.1 ± 22.9 | 112.8 ± 28.7 | 114.6 ± 34.3 | 1.9 ± 21.9 |
| 20° | 80.7 ± 24.4 | 82.7 ± 27.9 | 2.0 ± 19.6 | 82.3 ± 23.0 | 81.5 ± 28.0 | -0.7 ± 17.7 |
| Focal cartilage lesion | ||||||
| 70° | 114.9 ± 64.8 | 153.5 ± 61.7 | 38.6 ± 39.6 | 163.8 ± 58.5 | 176.4 ± 57.7 | 12.5 ± 30.5 |
| 60° | 125.1 ± 67.6 | 168.2 ± 61.4 | 43.1 ± 40.8 | 184.2 ± 60.0 | 195.7 ± 55.1 | 11.6 ± 34.4 |
| 50° | 122.2 ± 61.4 | 156.6 ± 51.6 | 34.4 ± 45.1 | 178.4 ± 52.7 | 186.4 ± 50.0 | 8.0 ± 38.4 |
| 40° | 109.1 ± 50.4 | 135.2 ± 43.5 | 26.2 ± 41.4 | 154.3 ± 44.4 | 159.8 ± 45.3 | 5.4 ± 37.3 |
| 30° | 93.0 ± 38.6 | 112.9 ± 34.9 | 20.0 ± 31.7 | 125.3 ± 34.8 | 128.4 ± 37.8 | 3.1 ± 31.2 |
| 20° | 74.5 ± 29.0 | 87.4 ± 28.5 | 12.9 ± 24.8 | 94.5 ± 29.2 | 96.8 ± 32.2 | 2.3 ± 27.0 |
Data are presented as mean ± SD. ACL, anterior cruciate ligament.
Figure 1.Mean angle-specific deficits at baseline (anterior cruciate ligament [ACL], n = 144; meniscus, n = 62; cartilage, n = 42).
Figure 2.Mean angle-specific deficits at postintervention retest (anterior cruciate ligament [ACL], n = 144; meniscus, n = 62; cartilage, n = 42).